PETRALIA, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 8.140
NA - Nord America 3.511
AS - Asia 2.245
SA - Sud America 209
OC - Oceania 56
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.186
Nazione #
DE - Germania 4.150
US - Stati Uniti d'America 3.447
GB - Regno Unito 1.226
IT - Italia 1.080
CN - Cina 957
SE - Svezia 569
SG - Singapore 555
RU - Federazione Russa 255
IE - Irlanda 180
IN - India 166
BR - Brasile 158
FR - Francia 129
NL - Olanda 106
HK - Hong Kong 104
ID - Indonesia 92
FI - Finlandia 84
TR - Turchia 83
KR - Corea 82
UA - Ucraina 74
DK - Danimarca 72
CA - Canada 54
AU - Australia 51
JP - Giappone 49
PH - Filippine 49
BE - Belgio 42
EU - Europa 37
ES - Italia 35
VN - Vietnam 33
AT - Austria 29
CH - Svizzera 21
CO - Colombia 19
NO - Norvegia 19
GR - Grecia 15
PL - Polonia 14
IR - Iran 11
PE - Perù 9
RO - Romania 9
CL - Cile 8
PT - Portogallo 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
EC - Ecuador 6
MX - Messico 6
TW - Taiwan 6
AR - Argentina 5
MA - Marocco 5
NZ - Nuova Zelanda 5
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
MY - Malesia 4
NG - Nigeria 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KZ - Kazakistan 3
PK - Pakistan 3
RS - Serbia 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IQ - Iraq 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
PA - Panama 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 14.222
Città #
Frankfurt am Main 3.835
Southend 1.041
Chandler 428
Singapore 364
Milan 334
Fairfield 279
Seattle 231
Princeton 197
Ashburn 185
Wilmington 180
Dublin 175
Beijing 174
Council Bluffs 163
Dearborn 129
Woodbridge 119
Ann Arbor 118
Houston 115
Cambridge 97
Santa Clara 85
Nanjing 83
Jakarta 82
Rome 65
Bengaluru 64
Des Moines 63
Hong Kong 63
Phoenix 59
Shanghai 55
Jacksonville 47
Mountain View 45
Munich 43
Redmond 42
Jinan 39
Redwood City 38
Brussels 36
Helsinki 36
Berlin 35
Florence 32
Guangzhou 31
Los Angeles 31
Boardman 29
Shenyang 26
Toronto 26
Hangzhou 23
Nuremberg 23
Sakarya 23
Turin 23
Central District 22
Changsha 22
Silver Spring 22
Hyderabad 20
London 20
Sydney 20
Tokyo 20
Dong Ket 19
New York 19
Andover 18
Bogotá 18
Eitensheim 17
Serra 17
Tianjin 17
Madrid 16
San Diego 16
Athens 15
Istanbul 15
Nanchang 15
Oslo 15
São Paulo 15
Jiaxing 14
Somerville 14
Amsterdam 13
Kunming 13
Quanzhou 13
Wuhan 13
Fremont 12
Bühl 11
Fuzhou 11
Hefei 11
Seoul 11
Grafing 10
Hebei 10
Medford 10
Melbourne 10
Naples 10
Zhengzhou 10
Bari 9
Buffalo 9
Chengdu 9
Chicago 9
Chongqing 9
Lappeenranta 9
Ningbo 9
Paris 9
Taiyuan 9
Vienna 9
Haikou 8
Manila 8
Rozzano 8
Venaria Reale 8
Catania 7
Duncan 7
Totale 10.121
Nome #
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 368
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 292
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 287
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy 231
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 231
Anterior prostatic tumours are difficult to diagnose without MRI 218
US-guided transcutaneous tru-cut biopsy of laryngo-hypopharyngeal lesions 216
Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: Review and recommendations 216
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 214
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 212
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 203
Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma 201
Sarcoidosis with bone involvement mimicking metastatic disease at 18F-FDG PET/CT : Problem solving by diffusion whole-body MRI 200
Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients 196
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 188
Whole-body magnetic resonance imaging (WB-MRI) in oncology : recommendations and key uses 188
Small colorectal cystic metastases to the liver : still a diagnostic dilemma? A report of a case and a review of the literature 186
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 185
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 181
Long survival in a patient with brain metastases from breast cancer 180
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 178
Contrast-enhanced ultrasound sonography optimises the assessment of lymph nodes in oncology 176
METastasis Reporting and Data System for Prostate Cancer : Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer 174
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer 172
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 172
Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study 164
Rationale for Modernising Imaging in Advanced Prostate Cancer 163
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 163
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 162
CT perfusion in solid-body tumours. Part I: technical issues 162
High-performance prediction models for prostate cancer radiomics 161
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 160
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 158
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 157
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 157
Intraobserver and interobserver variability in the calculation of apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance imaging (DW-MRI) of breast tumours 152
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer : a review 152
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 152
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 147
Surgical damage control treatment of a large retroperitoneal liposarcoma encasing a horseshoe kidney 146
Quantification of Variability in Breath-hold Perfusion CT of Hepatocellular Carcinoma : A Step toward Clinical Use 146
DCE-MRI and DWI integration for breast lesions assessment and heterogeneity quantification 146
[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning 145
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 145
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 141
Extramedullary myeloid sarcoma of the breast 140
CT perfusion in oncology: how to do it 139
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging 138
Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response 137
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 137
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 136
Stadiazione locale del tumore del retto 132
Perfusion CT in solid body-tumours. Part II: Clinical applications and future development 132
Whole-body diffusion-weighted imaging : is it all we need for detecting metastases in melanoma patients? 132
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 130
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 130
Investigating cancer patient acceptance of Whole Body MRI 129
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer 127
Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance : Which Features Matter? 126
CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma : initial experience 122
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 121
Quality assurance for automatically generated contours with additional deep learning 120
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 119
Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer 117
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion 116
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer 114
DW-MRI of the urogenital tract: Applications in oncology 113
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 113
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison 113
Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume 109
Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis 109
Tumors of the gastro-intestinal tract part A: Rectal cancer 106
Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer : a phase II study 105
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis 104
Erratum: Small colorectal cystic metastases to the liver: Still a diagnostic dilemma? A report of a case and a review of the literature 104
Uro-oncologic patient management during the COVID-19 pandemic: Survey findings from an Italian oncologic hub 104
Is whole-body magnetic resonance imaging a source of anxiety in oncological patients? 99
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer 99
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 97
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation? 97
Salvage therapy of small volume prostate cancer nodal failures : a review of the literature 96
Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study 96
Finding Minimal Extraprostatic Disease : Who Cares? 96
Automatic Segmentation with Deep Learning in Radiotherapy 95
Cognitive alterations and brain functional changes following chemotherapy treatment in breast cancer patients: A systematic review on resting-state fMRI studies 93
Local Staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection 93
Magnetic Resonance Imaging before Prostate Biopsy : Time to Talk 90
Sclerosing angiomatoid nodular transformation of the spleen during pregnancy : diagnostic challenges and clinical management 89
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time 88
Breast MR with special focus on DW-MRI and DCE-MRI 87
Future challenges in head and neck cancer: From the bench to the bedside? 86
Psychological characteristics and satisfaction for the whole-body MRI in cancer screening 85
Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience 84
Effects of MRI image normalization techniques in prostate cancer radiomics 82
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature 78
Semi-automated Segmentation of Bone Metastases from Whole-Body MRI: Reproducibility of Apparent Diffusion Coefficient Measurements 78
Impact of intra- and interobserver variability and of arterial input selection in perfusion CT measurement performed in squamous cell carcinoma of the upper aero-digestive tract 76
Whole body MRI for systemic staging of breast cancer in pregnant women 76
Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria 75
Multimodal MRI-based tissue classification in breast ductal carcinoma 75
Totale 14.228
Categoria #
all - tutte 40.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020275 0 0 0 0 0 0 0 0 0 162 59 54
2020/20211.160 110 85 56 55 86 159 70 70 167 106 132 64
2021/20221.429 82 61 91 91 117 98 73 70 164 148 136 298
2022/20231.865 284 202 158 164 152 315 63 138 180 33 119 57
2023/20243.763 62 71 80 73 260 152 573 524 275 499 594 600
2024/20253.255 589 546 484 447 270 216 141 364 194 4 0 0
Totale 14.808